Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|13|7|735-748

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.7, 2013-09, pp. : 735-748

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in Immunotherapy of Chronic Myeloid Leukemia CML

By  

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-09 ,pp. : 768-774

Bentham Science Publishers

Access to resources Recommend Favorite

Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives

By  

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-01 ,pp. : 775-778

Bentham Science Publishers

Access to resources Recommend Favorite

Novel and Emerging Drugs for Acute Myeloid Leukemia: Pharmacology and Therapeutic Activity

By  

Current Medicinal Chemistry, Vol. 18, Iss. 5, 2011-02 ,pp. : 638-666

Bentham Science Publishers

Access to resources Recommend Favorite

Signal transduction in Acute Myeloid Leukemia – Implications for Novel Therapeutic Concepts.

By  

Current Cancer Drug Targets, Vol. 15, Iss. 9, 2015-11 ,pp. : 803-821

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Hypermethylation of Myeloid Cells, A Novel Therapeutic Target in MDS and AML

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-01 ,pp. : 315-321

Bentham Science Publishers

Access to resources Recommend Favorite